Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Valproic acid does not change biotinidase enzyme activity in children's blood.

Coal tar shampoo increases enzyme activity in hair follicles, enhancing carcinogen binding to DNA.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Bortezomib chemotherapy can cause temporary skin rashes.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Taking too much Albendazole can cause hair loss and other serious side effects.

Taking too much Albendazole can cause hair loss and other serious side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The combination of encorafenib and binimetinib caused few skin issues.

Analog 23 is a promising compound for prostate cancer treatment.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

The treatment is safe and shows promise for metastatic breast cancer.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Newly made nicotinamide compounds could potentially treat cancer.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.